Furthermore, studies in a transgenic PD model demonstrated that microglial activation and the production of pro-inflammatory cytokines such as TNFα, IFNγ, and IL-1β precedes neurotoxicity [318,319], and inhibition of these cytokines suppresses microglia-mediated neurodegeneration [57]. The gene discussed is IL1B; the disease is Parkinson disease.